Data is not available at this time.
LNA Santé SA operates as a key player in France’s healthcare sector, specializing in the management of retirement homes, medical rehabilitation centers, mental health clinics, and home hospital services. The company’s revenue model is anchored in long-term care contracts and fee-for-service arrangements, ensuring stable cash flows from both public and private payers. Its diversified portfolio across care segments mitigates reliance on any single service line, enhancing resilience against regulatory or demand fluctuations. Positioned in a fragmented market, LNA Santé leverages its regional expertise and operational scale to maintain cost efficiency while adhering to France’s stringent healthcare standards. The aging population in Europe, particularly in France, provides a structural tailwind for its core retirement home and rehabilitation services. However, competition from non-profit providers and public hospitals necessitates continuous investment in care quality and facility modernization to sustain its market share. The company’s focus on integrated care pathways—spanning acute, post-acute, and home-based services—positions it as a holistic provider in a sector increasingly prioritizing patient-centric models.
LNA Santé reported revenue of €806.6 million for the period, with net income of €21.8 million, reflecting a modest net margin of approximately 2.7%. Operating cash flow of €82.1 million underscores solid cash generation, though capital expenditures of €12.2 million indicate ongoing investments in facility maintenance and upgrades. The diluted EPS of €2.04 suggests efficient use of equity capital despite sector-wide cost pressures.
The company’s operating cash flow-to-revenue ratio of ~10.2% demonstrates reasonable earnings power, though high debt levels may constrain near-term flexibility. With €75.1 million in cash against €876.4 million in total debt, interest coverage remains a focus area. Asset turnover appears stable given the capital-intensive nature of healthcare facilities.
LNA Santé’s balance sheet carries significant leverage, with total debt exceeding €876 million against a market cap of €245 million. While cash reserves provide liquidity, the debt-to-equity ratio suggests reliance on refinancing. The sector’s defensive cash flows may support debt servicing, but prolonged high interest rates could pressure financial metrics.
Organic growth is likely tied to France’s aging demographics, with limited near-term expansion signals beyond maintenance capex. A dividend of €0.6 per share implies a payout ratio of ~29%, balancing shareholder returns with reinvestment needs. Revenue growth trends should align with broader healthcare inflation and occupancy rates in its facilities.
At a market cap of €245 million, the stock trades at ~12x trailing earnings, a discount to broader healthcare peers, reflecting its leveraged position and regional focus. The beta of 0.7 indicates lower volatility versus the market, typical for defensive healthcare operators.
LNA Santé’s regional density and integrated care model provide competitive moats, but scalability beyond France remains untested. Regulatory risks and labor costs are persistent headwinds. The outlook hinges on debt management and France’s healthcare funding policies, with long-term demand underpinned by demographic trends.
Company filings, Euronext Paris disclosures
show cash flow forecast
| Fiscal year | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 | 2035 | 2036 | 2037 | 2038 | 2039 | 2040 | 2041 | 2042 | 2043 | 2044 | 2045 | 2046 | 2047 | 2048 | 2049 | |
INCOME STATEMENT | ||||||||||||||||||||||||||
| Revenue growth rate, % | NaN | |||||||||||||||||||||||||
| Revenue, $ | NaN | |||||||||||||||||||||||||
| Variable operating expenses, $m | NaN | |||||||||||||||||||||||||
| Fixed operating expenses, $m | NaN | |||||||||||||||||||||||||
| Total operating expenses, $m | NaN | |||||||||||||||||||||||||
| Operating income, $m | NaN | |||||||||||||||||||||||||
| EBITDA, $m | NaN | |||||||||||||||||||||||||
| Interest expense (income), $m | NaN | |||||||||||||||||||||||||
| Earnings before tax, $m | NaN | |||||||||||||||||||||||||
| Tax expense, $m | NaN | |||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
BALANCE SHEET | ||||||||||||||||||||||||||
| Cash and short-term investments, $m | NaN | |||||||||||||||||||||||||
| Total assets, $m | NaN | |||||||||||||||||||||||||
| Adjusted assets (=assets-cash), $m | NaN | |||||||||||||||||||||||||
| Average production assets, $m | NaN | |||||||||||||||||||||||||
| Working capital, $m | NaN | |||||||||||||||||||||||||
| Total debt, $m | NaN | |||||||||||||||||||||||||
| Total liabilities, $m | NaN | |||||||||||||||||||||||||
| Total equity, $m | NaN | |||||||||||||||||||||||||
| Debt-to-equity ratio | NaN | |||||||||||||||||||||||||
| Adjusted equity ratio | NaN | |||||||||||||||||||||||||
CASH FLOW | ||||||||||||||||||||||||||
| Net income, $m | NaN | |||||||||||||||||||||||||
| Depreciation, amort., depletion, $m | NaN | |||||||||||||||||||||||||
| Funds from operations, $m | NaN | |||||||||||||||||||||||||
| Change in working capital, $m | NaN | |||||||||||||||||||||||||
| Cash from operations, $m | NaN | |||||||||||||||||||||||||
| Maintenance CAPEX, $m | NaN | |||||||||||||||||||||||||
| New CAPEX, $m | NaN | |||||||||||||||||||||||||
| Total CAPEX, $m | NaN | |||||||||||||||||||||||||
| Free cash flow, $m | NaN | |||||||||||||||||||||||||
| Issuance/(repurchase) of shares, $m | NaN | |||||||||||||||||||||||||
| Retained Cash Flow, $m | NaN | |||||||||||||||||||||||||
| Pot'l extraordinary dividend, $m | NaN | |||||||||||||||||||||||||
| Cash available for distribution, $m | NaN | |||||||||||||||||||||||||
| Discount rate, % | NaN | |||||||||||||||||||||||||
| PV of cash for distribution, $m | NaN | |||||||||||||||||||||||||
| Current shareholders' claim on cash, % | NaN |